尊龙·凯时(官网)人生就是博!尊龙凯时

3SBio Group has always been committed to solving the problem of
clinical drug use for patients, constantly conquering the challenges
of the disease, using high-quality drugs to improve the quality of
life of patients, and working hard for the benefit of human health.

Cooperation partners

  • Exclusive license for the commercialization of GLP-1 products in China

  • Exclusive license to develop and commercialize programmed therapeutic cells in Greater China

  • Exclusive license for the distribution and promotion of insulin products

  • Collaboration for clinical development and commercialization of MCM1 in China

尊龙凯时